David S Klimstra
Overview
Explore the profile of David S Klimstra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
364
Citations
21598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Reid M, Klimstra D
Arch Pathol Lab Med
. 2023 Feb;
147(3):265-266.
PMID: 36848528
No abstract available.
12.
Wang T, Askan G, Ozcan K, Rana S, Zehir A, Bhanot U, et al.
Arch Pathol Lab Med
. 2023 Feb;
147(12):1390-1401.
PMID: 36821179
Context.—: Tumoral (grossly visible) intraductal neoplasms of the bile ducts are still being characterized. Objective.—: To investigate their morphologic, immunohistochemical, and molecular features. Design.—: Forty-one cases were classified as gastric-,...
13.
Raciti P, Sue J, Retamero J, Ceballos R, Godrich R, Kunz J, et al.
Arch Pathol Lab Med
. 2022 Dec;
147(10):1178-1185.
PMID: 36538386
Context.—: Prostate cancer diagnosis rests on accurate assessment of tissue by a pathologist. The application of artificial intelligence (AI) to digitized whole slide images (WSIs) can aid pathologists in cancer...
14.
Javed A, Pulvirenti A, Zheng J, Michelakos T, Sekigami Y, Razi S, et al.
Surgery
. 2022 Oct;
172(6):1800-1806.
PMID: 36192215
Background: Nonfunctional pancreatic neuroendocrine tumors display a wide range of biological behavior, and nodal disease is associated with metastatic disease and poorer survival. The aim of this study was to...
15.
Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens L, et al.
Endocr Pathol
. 2022 Mar;
33(1):115-154.
PMID: 35294740
In this review, we detail the changes and the relevant features that are applied to neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine and Neuroendocrine Tumors. Using a...
16.
Ozcan K, Klimstra D
Arch Pathol Lab Med
. 2022 Feb;
146(3):298-311.
PMID: 35192699
Context.—: Although most pancreatic and bile duct neoplasms are solid, mucinous cystic neoplasms and intraductal neoplasms have been increasingly recognized even when clinically silent, thanks to the increased use of...
17.
Reid M, Klimstra D
Arch Pathol Lab Med
. 2022 Feb;
146(3):278-279.
PMID: 35192698
No abstract available.
18.
Ardon O, Reuter V, Hameed M, Corsale L, Manzo A, Sirintrapun S, et al.
Acad Pathol
. 2022 Feb;
8:23742895211010276.
PMID: 35155745
Implementation of an infrastructure to support digital pathology began in 2006 at Memorial Sloan Kettering Cancer Center. The public health emergency and COVID-19 pandemic regulations in New York City required...
19.
Parilla M, Chapel D, Hechtman J, Wanjari P, Jabbour T, Sharma A, et al.
Am J Surg Pathol
. 2022 Feb;
46(6):823-831.
PMID: 35125451
Chromosomal aneuploidies are prognostic markers across a wide variety of tumor types, and recent literature suggests that pancreatic neuroendocrine tumors are no different. In this study 214 patients with grade...
20.
Hayashi A, Fan J, Chen R, Ho Y, Makohon-Moore A, Lecomte N, et al.
Nat Cancer
. 2022 Feb;
1(1):59-74.
PMID: 35118421
Pancreatic cancer expression profiles largely reflect a classical or basal-like phenotype. The extent to which these profiles vary within a patient is unknown. We integrated evolutionary analysis and expression profiling...